You have it all wrong! DNDN will be Biodels bit$$. DNDN has 135 million shares out compared to 23 million. Look at the percentage of ownership. Also once approved I am sure it will not cost 93,000 dollars a year. The Diabetes market is large and growing! Cant wait to see the shorts torn apart.